Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Allen Bloom currently holds 332,015 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allen Bloom has been a net buyer of CYTO stock. They have purchased $2.7K and sold $0 worth of shares.
Allen Bloom's most recent insider trade was on Jul 6, 2011, when they sold 17,308 shares at $1.04 per share.
Allen Bloom serves as Executive at CYTOGEN CORP (CYTO). They have executed 17 insider transactions totaling $2.7K over their tenure at the company.
Allen Bloom holds the position of Executive at CYTOGEN CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Allen Bloom has shown a buying trading pattern, with $2.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Allen Bloom was on Dec 17, 2010, when they sold $70.5K worth of UGNE shares. This transaction involved 150,000 shares at $0.47 per share.
Allen Bloom currently owns 332,015 shares of CYTOGEN CORP (CYTO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Allen Bloom's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Allen Bloom has 17 Form 4 filings on record as an insider at CYTOGEN CORP.
Set alerts for Allen Bloom and 40,000+ other insiders.